Long-Term Heart Rate Reduction Induced by the Selective If Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in … P Mulder, S Barbier, A Chagraoui, V Richard, JP Henry, F Lallemand, ... Circulation 109 (13), 1674-1679, 2004 | 437 | 2004 |
Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats G Derumeaux, P Mulder, V Richard, A Chagraoui, C Nafeh, F Bauer, ... Circulation 105 (13), 1602-1608, 2002 | 218 | 2002 |
High-affinity [3H] GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system JJ Bonnet, P Protais, A Chagraoui, J Costentin European journal of pharmacology 126 (3), 211-222, 1986 | 123 | 1986 |
Selenoprotein T exerts an essential oxidoreductase activity that protects dopaminergic neurons in mouse models of Parkinson's disease L Boukhzar, A Hamieh, D Cartier, Y Tanguy, I Alsharif, M Castex, A Arabo, ... Antioxidants & Redox Signaling 24 (11), 557-574, 2016 | 118 | 2016 |
5-HT2C receptors in psychiatric disorders: a review A Chagraoui, F Thibaut, M Skiba, C Thuillez, M Bourin Progress in Neuro-Psychopharmacology and Biological Psychiatry 66, 120-135, 2016 | 114 | 2016 |
L-DOPA in parkinson’s disease: Looking at the “false” neurotransmitters and their meaning A Chagraoui, M Boulain, L Juvin, Y Anouar, G Barrière, ... International journal of molecular sciences 21 (1), 294, 2019 | 73 | 2019 |
The PACAP-regulated gene selenoprotein T is highly induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes Y Tanguy, A Falluel-Morel, S Arthaud, L Boukhzar, DL Manecka, ... Endocrinology 152 (11), 4322-4335, 2011 | 71 | 2011 |
Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats A Chagraoui, P Protais, T Filloux, E Mocaër Psychopharmacology 170, 17-22, 2003 | 62 | 2003 |
Enantioselective Syntheses of Dopaminergic (R)- and (S)-Benzyltetrahydroisoquinolines N Cabedo, I Andreu, MC Ramirez de Arellano, A Chagraoui, A Serrano, ... Journal of medicinal chemistry 44 (11), 1794-1801, 2001 | 57 | 2001 |
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors M Vasse, A Chagraoui, P Protais European journal of pharmacology 148 (2), 221-229, 1988 | 55 | 1988 |
Constitutive activity of 5-HT receptors: Factual analysis P De Deurwaerdère, R Bharatiya, A Chagraoui, G Di Giovanni Neuropharmacology 168, 107967, 2020 | 53 | 2020 |
Structure–affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity M Asencio, C Hurtado-Guzmán, JJ López, BK Cassels, P Protais, ... Bioorganic & medicinal chemistry 13 (11), 3699-3704, 2005 | 46 | 2005 |
In vivo binding of [3H] GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum A Chagraoui, JJ Bonnet, P Protais, J Costentin Neuroscience letters 78 (2), 175-179, 1987 | 35 | 1987 |
WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women F Thibaut, A Chagraoui, L Buckley, F Gressier, J Labad, S Lamy, ... The World Journal of Biological Psychiatry 20 (1), 17-50, 2019 | 33 | 2019 |
Effects of some antioxidative aporphine derivatives on striatal dopaminergic transmission and on MPTP-induced striatal dopamine depletion in B6CBA mice F Loghin, A Chagraoui, M Asencio, E Comoy, H Speisky, BK Cassels, ... European journal of pharmaceutical sciences 18 (2), 133-140, 2003 | 33 | 2003 |
Interactions of amineptine with the neuronal dopamine uptake system: Neurochemicalin vitro andin vivo studies JJ Bonnet, A Chagraoui, P Protais, J Costentin Journal of neural transmission 69, 211-220, 1987 | 32 | 1987 |
Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats P De Deurwaerdère, M Ramos, R Bharatiya, E Puginier, A Chagraoui, ... Neuropharmacology 166, 107915, 2020 | 29 | 2020 |
Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models I Alsharif, L Boukhzar, B Lefranc, D Godefroy, J Aury-Landas, JL Do Rego, ... Redox biology 40, 101839, 2021 | 26 | 2021 |
Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents P Protais, A Chagraoui, J Arbaoui, E Mocaër European journal of pharmacology 271 (1), 167-177, 1994 | 26 | 1994 |
Neurochemical impact of the 5-HT2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain A Chagraoui, S Whitestone, L Baassiri, J Manem, G Di Giovanni, ... Neurochemistry International 124, 245-255, 2019 | 24 | 2019 |